Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.

Source:http://linkedlifedata.com/resource/pubmed/id/8058730

Proc. Natl. Acad. Sci. U.S.A. 1994 Aug 16 91 17 7889-93

Download in:

View as

Triples

General Info

PMID
8058730